Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 3 to 12

Lactium premedication to see if it prevents emergence agitation after adenotonsillectomy

Official title: Lactium Premedication to Prevent Emergence Agitation: A Dose-Finding Study in Children Undergoing Adenotonsillectomy

Run by Tanta University · NCT07894484 · Data updated 2026-11-12

A preoperative dose of Lactium is tested to see if it prevents emergence agitation in children after adenotonsillectomy.

More Adenotonsillectomy trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages3 Years to 12 Years
SexAll
Enrollment40 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Gharbia Governorate)
StatusRecruiting
StartedNovember 4, 2026
Main results expectedDecember 4, 2026
Study endsDecember 18, 2026
Registry record updatedNovember 5, 2026
Trial IDNCT07894484 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3–12 years with ASA I–II scheduled for adenotonsillectomy under sevoflurane anesthesia.

Probably not a fit

Children with contraindications to milk-derived products, significant neurological or developmental issues, or those taking anticonvulsants or sedatives may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase 3, dose-finding study uses a biased coin sequential allocation to identify the oral Lactium dose that prevents emergence agitation in 90% of children undergoing adenotonsillectomy with sevoflurane anesthesia. Lactium is a milk-derived peptide thought to act on GABA-A receptors to reduce anxiety and stress. The trial will enroll children aged 3–12 with ASA I–II and will compare escalating doses to determine the ED90. The primary goal is to establish a safe and effective premedication dose prior to surgery.

Why it matters

Potential benefit: If successful, a specific Lactium dose could reduce emergence agitation in most children after adenotonsillectomy, improving recovery comfort and safety.

How similar studies have gone: Prior work suggests milk-derived peptides can influence perioperative anxiety, but this exact dose-finding approach for emergence agitation is novel in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 3 to 12 years
* American Society of Anesthesiologist (ASA) Status I or II
* Planned for an adenotonsillectomy procedure under sevoflurane general anesthesia.

Exclusion Criteria:

* Parents declined to participate in the trial
* Behavioral changes, neurological or psychiatric problems
* Anticonvulsant or sedative drugs
* Physical or developmental abnormalities
* cardiovascular, renal, or gastrointestinal diseases.

Where it's running

  • Tanta University Hospitals
    Tanta, Gharbia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.